See how top analysts and institutions rate FHN — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Evercore ISI | Downgrade | Outperform → In-line | $20 | 2025-10-16 |
| DA Davidson | Initiated | Neutral | $24 | 2025-09-26 |
| TD Cowen | Initiated | Hold | $25 | 2025-09-25 |
| Jefferies | Initiated | Buy | $25 | 2025-05-21 |
| Truist | Initiated | Hold | $21 | 2025-05-13 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 3 | 6 | 9 | 0 | 0 |
| October 2025 | 3 | 7 | 8 | 0 | 0 |
| September 2025 | 3 | 7 | 6 | 0 | 0 |
| July 2025 | 3 | 7 | 6 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for FHN, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
